Forum for Science, Industry and Business
  • Sponsored by:
  • Siemens
  • Siemens
  • Siemens
Search our Site:

Topic (optional):

 

Home Reports Health and Medicine Content

Aspirin is most cost effective way to prevent heart disease

next article
28.11.2003

 


Aspirin and blood pressure lowering drugs can prevent heart disease at a fraction of the cost of cholesterol lowering drugs (statins) and clopidogrel (an anti-clotting drug), finds a study in this week’s BMJ.


Estimates of cost and effectiveness were obtained for aspirin, antihypertensive drugs, statins and clopidogrel. Cost per coronary event was calculated for treatments individually and in combination for patients at various levels of risk.

The most cost effective preventive treatments were aspirin and antihypertensive drugs, whereas simvastatin and clopidogrel were the least cost effective.

For instance, cost per coronary event prevented in a patient at 10% risk over five years was £3,500 for aspirin, £12,500 for initial antihypertensives, £18,300 for intensive antihypertensives, £60,000 for clopidogrel, and £61,400 for simvastatin.

These results cast doubt on present policy, says the author. A more efficient prevention strategy would be to offer most men over 55 and most women over 65 aspirin than to give statins to a few high-risk patients.

Emma Dickinson | Source: alphagalileo
Further information: press.psprings.co.uk/bmj/november/gp1264.pdf

next article

More articles from Health and Medicine:

nachricht Colonial Urbanization in Africa at Dawn of 20th Century Marked Outbreak of HIV
02.10.2008 | University of Arizona

nachricht Brain Signal Persists Even in Dreamless Sleep
02.10.2008 | Washington University in St. Louis

B2B Search

Product / Service
Company / Organisation

Latest News

Cells that Avoid Suicide May Become Cancerous

02.10.2008 | Life Sciences

VTT, Turku University Hospital and Gothenburg University studying how gut microbes affect on progression of type 1 diabetes

02.10.2008 | Life Sciences

New species thanks to different ways of seeing

02.10.2008 | Life Sciences